tyrosine has been researched along with Neuritis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Areti, A; Gogoi, R; Komirishetty, P; Kumar, A; Ruby, PK; Sharma, SS; Sistla, R; Yerra, VG | 1 |
| Davis, TP; Demarco, KM; Finch, JD; Lochhead, JJ; McCaffrey, G; Quigley, CE; Ronaldson, PT; Sanchez-Covarrubias, L | 1 |
| Dumitrescu, L; Heneka, MT; Klockgether, T; Löschmann, PA; Wüllner, U | 1 |
3 other study(ies) available for tyrosine and Neuritis
| Article | Year |
|---|---|
PARP inhibition attenuates neuroinflammation and oxidative stress in chronic constriction injury induced peripheral neuropathy.
Topics: Animals; Benzamides; Constriction, Pathologic; Cyclooxygenase 2; Hyperalgesia; Inflammation; Male; NAD; Neuritis; Neuroprotective Agents; Oxidative Stress; Pain Measurement; Peripheral Nervous System Diseases; Poly(ADP-ribose) Polymerase Inhibitors; Rats; Rats, Sprague-Dawley; Sensation; Tyrosine; Walking | 2016 |
Tempol modulates changes in xenobiotic permeability and occludin oligomeric assemblies at the blood-brain barrier during inflammatory pain.
Topics: Acute Disease; Aldehydes; Analgesics, Opioid; Animals; Antioxidants; Blood-Brain Barrier; Capillary Permeability; Carbon Radioisotopes; Codeine; Cyclic N-Oxides; Cysteine Proteinase Inhibitors; Hyperalgesia; Male; Membrane Proteins; Neuralgia; Neuritis; Occludin; Oxidative Stress; Rats; Rats, Sprague-Dawley; Spin Labels; Sucrose; Tight Junctions; Tyrosine; Xenobiotics | 2012 |
Temporal, regional, and cell-specific changes of iNOS expression after intrastriatal microinjection of interferon gamma and bacterial lipopolysaccharide.
Topics: Animals; Antineoplastic Agents; Astrocytes; Corpus Callosum; Corpus Striatum; Glial Fibrillary Acidic Protein; In Situ Nick-End Labeling; Interferon-gamma; Lipopolysaccharides; Male; Microglia; Microinjections; Neuritis; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Rats; Rats, Wistar; Tyrosine | 2000 |